Atlas Trials

A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

Clinical trial NCT03725475 · COMPLETED

Trial details

NCT number
NCT03725475
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Non-small-cell Lung Cancer (NSCLC)
Start date
2018-11-26
Primary completion
2019-09-30
Enrollment
3111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.